Rapid, Detection of Active versus Inactive Botulinum Toxin

Award Information
Agency: Department of Defense
Branch: Defense Advanced Research Projects Agency
Contract: W31P4Q-06-C-0087
Agency Tracking Number: 05SB2-0365
Amount: $99,000.00
Phase: Phase I
Program: SBIR
Awards Year: 2005
Solicitation Year: 2005
Solicitation Topic Code: SB052-023
Solicitation Number: 2005.2
Small Business Information
11609 Lake Potomac Drive, Potomac, MD, 20854
DUNS: 008723694
HUBZone Owned: N
Woman Owned: Y
Socially and Economically Disadvantaged: N
Principal Investigator
 Cha-Mei Tang
 (301) 983-1650
Business Contact
 Platte Amstutz
Title: CFO and Business Development
Phone: (301) 983-2553
Email: pete@creatvmicrotech.com
Research Institution
Clostridium botulinum neurotoxins (BoNT) are among the most poisonous substances known. Although production and dissemination of pure toxin is not trivial, it is highly feasible, making BoNT a potentially devastating bioweapon. Four serotypes A, B, E and F cause illness in humans. At present, the only method that is used with confidence to detect BoNT is the acute toxicity test performed with mice. This mouse bioassay has a number of drawbacks: it is expensive to perform, requires a large number of animals, takes four days to complete, and does not confirm toxin serotype unless carried out in parallel with antisera neutralization tests. Some immunoassays have demonstrated sensitivities similar to the mouse bioassay, but immunoassays alone do not indicate the toxin's proteolytic activity (the measure of its toxic action), which can lead to false positive results. CDC has demonstrated a sensitive BoNT detection method that determines proteolytic activity based on mass spectrometry, but its drawbacks are expensive instrumentation, the need for a highly trained operator, and 5-6 hours assay time. Dr. Cliff Shone of Health Protection Agency in the United Kingdom, has demonstrated two sensitive BoNT detection methods by immunoassay and by mass spectrometry, both of which require extensive manual operation and 5-6 hours assay time. We propose an assay, cartridge and an instrument to meet the critical need for a BoNT detection method. It will be better than the existing technologies because of the following characteristics:  Rapid - 2 to 3 hours  Sensitive - at least as sensitive as the mouse bioassay  Confirms toxin proteolytic activity  Portable, countertop instrument  Automated assay not requiring highly trained personnel Phase I of the proposal will demonstrate the part of the novel assay that demonstrates the activity of BoNT and sensitivity of the method.

* Information listed above is at the time of submission. *

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government